MIDWAY AIRLINES CORP
SC 13D/A, 1999-12-22
AIR TRANSPORTATION, SCHEDULED
Previous: PIXTECH INC /DE/, PRER14A, 1999-12-22
Next: MIDWAY AIRLINES CORP, SC 13D/A, 1999-12-22





                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  SCHEDULE 13D

                    UNDER THE SECURITIES EXCHANGE ACT OF 1934
                               (AMENDMENT NO. 2)*


                           MIDWAY AIRLINES CORPORATION
                     --------------------------------------
                                (Name of Issuer)


                     COMMON STOCK, PAR VALUE $.01 PER SHARE
                     --------------------------------------
                         (Title of Class of Securities)


                                   598126 10 0
                     ---------------------------------------
                                 (CUSIP Number)


                            James H. Goodnight, Ph.D.
                               SAS Institute, Inc.
                                SAS CAMPUS DRIVE
                           CARY, NORTH CAROLINA 27513
                             TEL. NO. (919) 677-8000
     ----------------------------------------------------------------------
            (Name, Address and Telephone Number of Person Authorized
                     to Receive Notices and Communications)


                                DECEMBER 17, 1999
                    -----------------------------------------
             (Date of Event which Requires Filing of this Statement)


If the filing person has previously  filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this

575964.2

<PAGE>



schedule because of ss.ss. 240.13d-1(e), 240.13d-l(f) or 240.13d-1(g), check the
following box / /.

NOTE:  Schedules  filed in paper format shall include a signed original and five
copies of the schedule,  including all exhibits.  See  ss.240.13d-7 for other
parties to whom copies are to be sent.

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).



1   NAME OF REPORTING PERSONS
    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (entities only)

    James H. Goodnight, Ph.D.

2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

      (a)   /   /

      (b) /X/

3   SEC USE ONLY


4   SOURCE OF FUNDS

     PF

5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
    ITEMS     2(d) OR 2(e)   / /



575964.2

<PAGE>



6   CITIZENSHIP OR PLACE OF ORGANIZATION

     U.S.

NUMBER OF             (7)    SOLE VOTING POWER
SHARES                       2,745,274
BENEFICIALLY
OWNED BY              (8)    SHARED VOTING POWER
EACH                         1,333,418 (if shared power included)
REPORTING
PERSON                (9)    SOLE DISPOSITIVE POWER
WITH                         2,745,274

                      (10)   SHARED DISPOSITIVE POWER
                             1,333,418 (if shared power included)

11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

      2,745,274 (4,078,692 if shared power included)


12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
      SHARES (See Instructions)  / /


13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     31.9% (47.4% if shared power included)


14  TYPE OF REPORTING PERSON

      IN





<PAGE>



                                  SCHEDULE 13D
                                       OF
                            JAMES H. GOODNIGHT, PH.D.


ITEM 1:  SECURITY AND ISSUER.

         This  Schedule 13D relates to the Common Stock (the "Common  Stock") of
Midway Airlines  Corporation,  a Delaware  corporation  (the  "Company"),  whose
principal  executive  offices  are  located  at 2801  Slater  Road,  Suite  200,
Morrisville, NC 27560.

ITEM 2:  IDENTITY AND BACKGROUND.

         The person filing this Schedule 13D is James H. Goodnight, Ph.D., whose
business address is SAS Campus Drive, Cary, North Carolina 27513.

ITEM 4:  PURPOSE OF TRANSACTION.

         On November 5, 1999,  Dr.  Goodnight  and John P. Sall  proposed to the
Board of  Directors  of the Company a merger of the Company with a new entity to
be formed by them. In the merger,  shares of Common Stock not currently owned by
Messrs.  Goodnight  and Sall  would have been  exchanged  for cash at a price of
$8.00 per share.  Following  rejection of the proposal by a Special Committee of
the Company's  Board of Directors  appointed to consider the  proposal,  Messrs.
Goodnight and Sall withdrew their merger proposal on December 17, 1999.

         In the future,  Messrs.  Goodnight and Sall may elect to buy additional
shares  of  Common  Stock  from  time  to  time  or at  any  time  in  brokerage
transactions  on the open market or in  privately  negotiated  transactions,  if
appropriate opportunities to do so are available, on such terms as they consider
desirable,   depending  on  their  continuing  assessment  of  certain  factors,
including,  without  limitation:  the Company's business,  financial  condition,
results of operations and prospects;  changes in the laws and regulations of the
United States and the various states concerning or affecting  airlines generally
and the  Company  specifically;  other  business  and  investment  opportunities
available;  the  prices at which  shares of Common  Stock are  trading;  general
economic conditions; and stock market and money market conditions.  They may act
in conjunction with each other with respect to their  respective  investments in
the  Company and in deciding  what future  action  either or both of them should
undertake with respect to their interests.


ITEM 5:  INTEREST IN SECURITIES OF THE ISSUER.

         As of the date hereof,  Dr. Goodnight  beneficially owns 2,745,274,  or
approximately  31.9%,  of the shares of Common  Stock  outstanding,  based on an
aggregate of 8,602,395  shares  outstanding.  Dr.  Goodnight has sole voting and
dispositive power with respect to all of these shares.


<PAGE>


         As Messrs.  Goodnight and Sall may act in  conjunction  with each other
with respect to their respective  investments in the Company, Dr. Goodnight may,
under rules and regulations of the Securities and Exchange Commission, be deemed
to share voting and  dispositive  power as to the shares  owned by Mr. Sall.  In
that case, Dr.  Goodnight  would own an aggregate of 4,078,692  shares of Common
Stock,  or 47.4% of the  shares  of  Common  Stock  outstanding.  Dr.  Goodnight
disclaims beneficial ownership of the shares of Common Stock owned by Mr. Sall.

                                    * * * * *

         After reasonable  inquiry and to the best of my knowledge and belief, I
certify that the information  set forth in this statement is true,  complete and
correct.

December 22, 1999                  /s/ James H. Goodnight
- -----------------------        ----------------------------------------
Date                                   James H. Goodnight, Ph.D.










<PAGE>




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission